One-third of congenital cytomegalovirus-related hearing loss would be missed without universal screening programs.

The FDA has cleared BrainsWay’s Deep Transcranial Magnetic Stimulation system for use as an adjunct therapy in adolescents with major depressive disorder.

The FDA has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.

The Trump administration directed visa officers to consider chronic health conditions when deciding whether to approve entry into the US.

Overall rates of nicotine vaping declined among US youth, but those who continue to vape are showing signs of worsening addiction.

Representation of minority groups among neurology residency applicants grew from 2007 to 2020, but matriculants remain underrepresented.

Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...

Lewy body dementia is often misdiagnosed as Alzheimer disease, despite high specificity of clinical diagnosis.

A new companion to the GSA KAER Toolkit for Brain Health helps clinicians and caregivers promote brain health, detect cognitive changes early, and support adults with intellectual and developmental ...

In honor of Epilepsy Awareness Month, experts highlight the importance of managing in utero exposure to anti-seizure medications during pregnancy.

Maternal SARS-CoV-2 infection is associated with an increased risk for adverse neurodevelopmental diagnoses among offspring.

There were modest reductions in cognitive performance seen for longer fasting intervals and for younger vs older participants during fasts.